Incyte CEO on New Drugs, Jakafi Applications

Feb. 20 (Bloomberg) -- Herve Hoppenot, chief executive officer of Incyte Corp., talks with Bloomberg’s Meg Tirrell about the company's Jakfi drug used to treat a bone marrow disorder called myelofibrosis, Incyte's drug pipeline and the outlook for growth. Shares of the cancer-drug maker have tripled in the last year. (Source: Bloomberg)

What's Holding Apple's IBeacon Back?
10:54 - After its launch two years ago, iBeacon, the location services technology from Apple that could make it possible to get precise coupons on your phone as you shopped fizzled. What exactly happened to the technology? Bloomberg's Josh Brustein reports on "Bloomberg Markets." (Source: Bloomberg)
  • Negroponte Doubts Warplane Shootdown Causes War
  • How Might Warplane Incident Impact Oil Prices?
  • Inside a 'Star Wars' Toy Business Success